We are live on ! Find out more
FLACU

Frazier Lifesciences Acquisition Corporation Unit

Delisted

FLACU was delisted on the 22nd of November, 2022.

26 hedge funds and large institutions have $46.4M invested in Frazier Lifesciences Acquisition Corporation Unit in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less capital invested

Capital invested by funds: $51.3M → $46.4M (-$4.92M)

19% less funds holding

Funds holding: 3226 (-6)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
26
Holders Change
-6
Holders Change %
-18.75%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
6
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
26
Millennium Management
New York
-$2.26M -225,001 Closed
BCM
27
BlueCrest Capital Management
Jersey
-$1M -100,000 Closed
BCM
28
Bluefin Capital Management
New York
-$682K -67,643 Closed
Walleye Trading
29
Walleye Trading
New York
-$121K -12,000 Closed
EAM
30
Exos Asset Management
New York
-$49K -4,888 Closed
WAM
31
Wolverine Asset Management
Illinois
-$7K -788 Closed

FLACU Hedge Fund Activity: Q3 2021 in Review

26 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Unit (FLACU) for Q3 2021, worth a combined $46.4M — down 9.6% from $51.3M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of FLACU and 0 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $2.95K. The largest seller was Millennium Management, exiting entirely with an estimated $2.26M sold.

  • 26 institutional investors held Frazier Lifesciences Acquisition Corporation Unit (FLACU) as of Q3 2021, down from 32 in Q2 2021.
  • Funds reported $46.4M of Frazier Lifesciences Acquisition Corporation Unit stock for Q3 2021, down 9.6% quarter-over-quarter.
  • 0 funds opened new Frazier Lifesciences Acquisition Corporation Unit positions in Q3 2021 and 6 closed out, a net change of -6 holders.
  • The largest Frazier Lifesciences Acquisition Corporation Unit buyer in Q3 2021 was UBS Group, an estimated $2.95K added.
  • The largest Frazier Lifesciences Acquisition Corporation Unit seller in Q3 2021 was Millennium Management, an estimated $2.26M sold.

Based on aggregated 13F filings for Q3 2021.